- Drugs
- Wednesday, 02 Aug 2023
Clinic Casting and Splinting Products Market is expected to reach US$ 2,085.57 million by 2030
Casting Segment Held Larger Share of Clinic Casting and Splinting Products Market by Product
According to our new research study on "Clinic Casting and Splinting Products Market Size and Forecast to 2030 – COVID-19 Impact and Global Analysis – by Product, Application, and Material," the market was valued at US$ 1,383.42 million in 2022 and is expected to reach US$ 2,085.57 million by 2030. It is estimated to register a CAGR of 5.3% during 2022–2030.
Orthopedic devices such as casts and splints are used to support and protect broken or injured bones and joints. To keep the broken bone in place while it heals completely, they assist in immobilizing the afflicted limb. Due to swelling in the injured area, splints are used immediately. A full cast may be put on the wounded limb once the swelling has reduced. Depending on the specific fracture type, the splint or cast may be worn from a few days to a couple of months. The main function of the cast is to maintain rigid alignment of bones as the body heals them over the course of several weeks or months.
Clinic Casting and Splinting Products Market, by Product, 2022-2030 (%)
To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00008646
Source: The Insight Partners Analysis
Based on product, the clinic casting and splinting products market is segmented into casting and splinting. In 2022, the casting segment accounted for a larger clinic casting and splinting products market share. However, the splinting segment is anticipated to register a higher CAGR during the forecast period. The major driving factors the growth of the casting segment is because when it comes to serious fractures, orthopedic casts are usually the best option. They are typically made from stronger materials than splints, making them more durable and less likely to break or come loose. A cast can be molded specifically as per the fracture's needs and worn for several weeks as needed. The cast is more rigid than the temporary splint, but both may feel heavy.
Impact of COVID-19 Pandemic on Clinic Casting and Splinting Products Market
During the COVID-19 pandemic, many countries imposed lockdowns to avoid the spread of novel coronavirus that causes COVID-19. As a result, there was a decrease in road accidents and workplace accidents, which dropped the number of fractures, sprains, and ligament damage cases. This hampered the clinic casting and splinting products market growth during the COVID-19 pandemic. However, due to an upsurge in home accidents caused by various reasons such as falls at home, cases of fractures or sprains increased during this period. This gradually increased the demand for clinic and splinting products.
DeRoyal Industries Inc, Prime Healthcare Services Inc, 3M Co, Corflex Inc, Essity AB, Dynatronics Corporation, Zimmer Biomet Holdings Inc, Ossur hf, Performance Health Holding Inc, and Enovis Corp are among the leading companies operating in the clinic casting and splinting products market.
The report segments the clinic casting and splinting products market as follows:
The clinic casting and splinting products market is segmented on the basis of product, application, and material. Based on product, the market is bifurcated into casting and splinting. In 2022, the casting segment accounted for a larger clinic casting and splinting products market share. In terms of application, the clinic casting and splinting products market is segmented into acute fractures or sprains, tendon and ligament injuries, and others. Based on material, the clinic casting and splinting products market is segmented into fiberglass, plaster of Paris, and others. Geographically, the clinic casting and splinting products market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Contact Us
Contact Us: The Insight Partners
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
Related Industry Updates
Small Cell Lung Cancer (SCLC) Treatment Market is expected to reach US$ 9,173.60 million by 2030
Dec 21, 2023
Oral Anti-Diabetes Drugs Market Size (Value & Volume), Future Trends, Opportunities and Sales Channels, Forecast 2027
Apr 06, 2021
Europe Pharmaceutical Continuous Manufacturing Market 2027 Growth Factors, Opportunities, Ongoing Trends with Top Companies Like Fette Compacting, KORSCH AG, LEISTRITZ AG, ALEXANDERWERK AG, Hovione
Dec 02, 2020
Algae Products Market 2021 Growth, Demand, And Value Is Increasing In The Upcoming Years
Mar 23, 2021
CytoSorb® approved by the EU to remove rivaroxaban, a Factor Xa inhibitor
May 13, 2020
Hikma launches Dicyclomine Hydrochloride Oral Solution
May 28, 2020
Vaccines: A Powerful Panacea to Impound Epidemic
Aug 19, 2019